Second high-dose chemotherapy intensification followed by hematopoietic stem cell transplantation applying a novel high-dose topotecan-based regimen in an adult Wilms' tumor patient: Case report

Anti-Cancer Drugs

Volumn 22, Issue 1, 2011, Pages 111-114

  Daladimos, Theodoros ^a   Theotikos, Evangelos ^a   Athanasopoulos, Aggelos ^b   Tsakonas, George ^a   Karabelis, Athanasios ^a   Mylonakis, Nikolaos ^a   Kosmas, Christos ^a  

^a Second Division of Medical Oncology   (Greece)

^b METAXA CANCER HOSPITAL   (Greece)

Author keywords

high dose chemotherapy; stem cell transplantation; topotecan; Wilms' tumor

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; PACLITAXEL; TOPOTECAN; VINCRISTINE;

ADRENAL FUNCTION; ADULT; ANEMIA; ARTICLE; CANCER RELAPSE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DRUG MEGADOSE; EPISTAXIS; FEBRILE NEUTROPENIA; GASTROINTESTINAL TOXICITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; KIDNEY DYSFUNCTION; LABORATORY TEST; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEPHRECTOMY; NEPHROBLASTOMA; PRIORITY JOURNAL; SALVAGE THERAPY; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOPOSIDE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY NEOPLASMS; MALE; MELPHALAN; NEPHRECTOMY; TOPOTECAN; WILMS TUMOR; YOUNG ADULT;

EID: 78650517511     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e328340189a     Document Type: Article

References (12)

1. Metzger ML, Dome JS. Current therapy for Wilms' tumor. Oncologist 2005; 10:815-826.
2. Grundy P, Breslow N, Green DM, Sharples K, Evans A, D'Angio GJ. Prognostic factors for children with recurrent Wilms' tumor: Results from the second and third National Wilms' Tumor Study. J Clin Oncol 1989; 7:638-647.
3. Abu-Ghosh AM, Krailo MD, Goldman SC, Slack RS, Davenport V, Morris E, et al. Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: A Children's Cancer Group report. Ann Oncol 2002; 13:460-469.
4. Garaventa A, Hartmann O, Bernard JL, Zucker JM, Pardo N, Castel V, et al. Autologous bone marrow transplantation for pediatric Wilms' tumor: The experience of the European Bone Marrow Transplantation Solid Tumor Registry. Med Pediatr Oncol 1994; 22:11-14.
5. Pein F, Michon J, Valteau-Couanet D, Quintana E, Frappaz D, Vannier JP, et al. High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: A French Society of Pediatric Oncology Study. J Clin Oncol 1998; 16:3295-3301.
6. Kremens B, Gruhn B, Klingebiel T, Hasan C, Laws HJ, Koscielniak E, et al. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma. Bone Marrow Transplant 2002; 30:893-898.
7. Campbell AD, Cohn SL, Reynolds M, Seshadri R, Morgan E, Geissler G, et al. Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: The experience at Children's Memorial Hospital. J Clin Oncol 2004; 22:2885-2890.
8. Spreafico F, Bisogno G, Collini P, Jenkner A, Gandola L, D'Angelo P, et al. Treatment of high-risk relapsed Wilms tumor with dose-intensive chemotherapy, marrow-ablative chemotherapy, and autologous hematopoietic stem cell support: Experience by the Italian Association of Pediatric Hematology and Oncology. Pediatr Blood Cancer 2008; 51:23-28.
9. Dallorso S, Dini G, Faraci M, Spreafico F; EBMT Paediatric Working Party. SCT for Wilms' tumour. Bone Marrow Transplant 2008; 41 (Suppl 2): S128-S130.
10. Maurer K, Heitger A, Schwaighofer H, Fink FM, Niederweiser D. Double high-dose chemotherapy with autologous peripheral stem cell rescue in relapsed Wilms' tumor. Bone Marrow Transplant 1997; 20:1111-1113.
11. Donato ML, Aleman A, Champlin RE, Saliba RM, Wharton JT, Burke TW, et al. Analysis of 96 patients with advanced ovarian carcinoma treated with high-dose chemotherapy and autologous stem cell transplantation. Bone Marrow Transplant 2004; 33:1219-1224.
12. Saylors RL III, Stewart CF, Zamboni WC,Wall DA, Bell B, Stine KC, Vietti TJ. Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: A Pediatric Oncology Group Study. J Clin Oncol 1998; 16:945-952.